BridgeMD
New treatment option for Breastfeeding
Official title Pumping to Up Maternal Milk Production for Preterms
ClinicalTrials.gov ID: NCT06673160
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn about the effect of breast-pumping frequency on breast milk supply/ volume in mothers of preterm infants. The main question it aims to answer is: \- What effect does pumping frequency have on breast milk supply.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages up to 28
You may be able to join if
- Inborn infants \<32 weeks gestation
- Out-born infants transferred to our facility \<48hours of life
- Infants \<1500 grams at birth
- Infants whose parents/ guardians have provided legal consent for study participation
You likely can't join if
- Infants with birthing persons' that are severe/critically ill
- Birthing persons of infants \<18 years old
- Infants with terminal illness or decision to withhold or limit support
- infants with major congenital anomalies, chromosomal disorders, or congenital infections
The study team makes the final eligibility decision.
Where it's taking place
- Birmingham, Alabama, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, up to 28 days. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Birmingham, Alabama, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.